Mechanism of decrease of protein synthesis by sodium cyanate in murine P388 leukemia cells

Area of Science:

• Biochemistry
• Molecular Biology
• Oncology

Background:

• Protein synthesis is crucial for cell function and proliferation.
• Cancer cells often exhibit altered protein synthesis regulation.
• Selective inhibitors of tumor cell protein synthesis are valuable therapeutic targets.

Purpose of the Study:

• To investigate the mechanism by which sodium cyanate (NaOCN) inhibits protein synthesis in P388 leukemia cells.
• To determine if NaOCN affects amino acid pools, transport, or nucleotide pools.
• To elucidate the specific stage of protein synthesis affected by NaOCN.

Main Methods:

• In vivo and in vitro protein synthesis assays using [14C]phenylalanine.
• Analysis of amino acid pools and nucleotide pools.
• Assessment of amino acid transport kinetics.
• Cell-free lysate experiments with exogenous tRNA and mRNA templates.
• Measurement of 48S initiation complex formation and mRNA synthesis.
• DNA synthesis assays.

Main Results:

• Sodium cyanate (NaOCN) significantly decreased protein synthesis in P388 leukemia cells without affecting normal tissues.
• NaOCN did not alter amino acid pools, transport, or nucleotide pools.
• Protein synthesis inhibition was linked to decreased 48S initiation complex formation and mRNA synthesis.
• DNA synthesis was also significantly inhibited by NaOCN.
• Ribosomal machinery and protein synthesis elongation were unaffected.

Conclusions:

• Sodium cyanate (NaOCN) selectively inhibits protein synthesis in tumor cells by targeting mRNA synthesis and translation initiation.
• NaOCN represents a potential therapeutic agent for cancer due to its selective action.
• The findings provide insights into the regulation of protein synthesis in cancer cells.